上海莼試生物技術(shù)有限公司
   
菜單 Close 公司首頁 公司介紹 公司動(dòng)態(tài) 產(chǎn)品展廳 證書榮譽(yù) 聯(lián)系方式 在線留言
您當(dāng)前的位置: 網(wǎng)站首頁 > 產(chǎn)品展廳 >抗體 >磷酸化磷脂酰肌醇激酶抗體規(guī)格
產(chǎn)品展廳
磷酸化磷脂酰肌醇激酶抗體規(guī)格
  • 品牌:上海莼試
  • 產(chǎn)地:進(jìn)口、國產(chǎn)
  • 貨號(hào):CS10814
  • 發(fā)布日期: 2019-01-04
  • 更新日期: 2025-04-18
產(chǎn)品詳請(qǐng)
產(chǎn)地 進(jìn)口、國產(chǎn)
品牌 上海莼試
保存條件 Store at -20 °C
貨號(hào) CS10814
應(yīng)用范圍 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
CAS編號(hào)
抗體名 Anti-phospho-PI3K p85/PIK3R1(Tyr368)
克隆性
靶點(diǎn) 詳見說明書
適應(yīng)物種 詳見說明書
形態(tài) 詳見說明書
宿主 詳見說明書
亞型 IgG
標(biāo)識(shí)物 詳見說明書
濃度 1mg/1ml%
免疫原 KLH conjugated Synthesised phosphopeptide derived from human PIK3R1 around the phosphorylation site of Tyr368 [GD(p-Y)TL]

全、新、優(yōu)、品、好四大特點(diǎn):

磷酸化磷脂酰肌醇激酶抗體規(guī)格 全:公司提供上萬種產(chǎn)品,涵蓋了生物試劑,elisa試劑盒,標(biāo)準(zhǔn)品,培養(yǎng)基,原裝耗材,抗體、培養(yǎng)基、ATCC細(xì)胞等,基本上各種科研所需產(chǎn)品在我司都能找到。

新:產(chǎn)品更新速度較快,基本上每周都有新產(chǎn)品出現(xiàn)。

優(yōu):產(chǎn)品質(zhì)量好,投訴比較少。

好:我公司具有優(yōu)質(zhì)的技術(shù)團(tuán)隊(duì),產(chǎn)品一旦售出,實(shí)驗(yàn)過程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時(shí)沒有任何的后顧之憂。

磷酸化磷脂酰肌醇激酶抗體規(guī)格 英文名稱  Anti-phospho-PI3K p85/PIK3R1(Tyr368)

中文名稱  磷酸化磷脂酰肌醇激酶抗體規(guī)格 

     PIK3R1(phospho Y368); GRB 1; GRB1; p85 alpha; p85; P85A_HUMAN; Phosphatidylinositol 3 kinase associated p 85 alpha; Phosphatidylinositol 3 kinase regulatory 1; Phosphatidylinositol 3 kinase regulatory subunit alpha; Phosphatidylinositol 3 kinase regulatory subunit polypeptide 1 (p85 alpha); Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha; Phosphatidylinositol 3-kinase regulatory subunit alpha; Phosphoinositide 3 kinase regulatory subunit 1 (alpha); Phosphoinositide 3 kinase regulatory subunit 1 (p85 alpha); Phosphoinositide 3 kinase regulatory subunit 1; Phosphoinositide 3 kinase regulatory subunit polypeptide 1 (p85 alpha); PI3 kinase p85 subunit alpha; PI3-kinase regulatory subunit alpha; PI3-kinase subunit p85-alpha; PI3K; PI3K regulatory subunit alpha; Pik3r1; PtdIns 3 kinase p85 alpha; PtdIns-3-kinase regulatory subunit alpha; PtdIns-3-kinase regulatory subunit p85-alpha.

產(chǎn)品屬性:

      1mg/1ml

規(guī)   0.1ml/100μg

抗體來源  Rabbit

克隆類型   polyclonal

交叉反應(yīng)   Human, Mouse, Rat, Dog, Pig, Cow, Horse

產(chǎn)品類型   一抗 磷酸化抗體  

研究領(lǐng)域     免疫學(xué) 信號(hào)轉(zhuǎn)導(dǎo) 激酶和磷酸酶

蛋白分子量  predicted molecular weight: 84kDa 

       Lyophilized or Liquid

  KLH conjugated Synthesised phosphopeptide derived from human PIK3R1 around the phosphorylation site of Tyr368 [GD(p-Y)TL]

      IgG

純化方法   affinity purified by Protein A

儲(chǔ)    0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide

磷酸化磷脂酰肌醇激酶抗體規(guī)格 產(chǎn)品應(yīng)用   WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

(石蠟切片需做抗原修復(fù)) 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存條件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

產(chǎn)品介紹 The enzyme phosphatidylinositol 3 kinase (PI3 kinase) is a lipid kinase that generates phosphatidylinositol 3, 4, 5-triphosphate in response to receptor activation in many signal transduction pathways. Class IA PI3Ks exist as a heterodimer of a catalytic 110 kDa (p110) and a regulatory p85 subunit (e.g. p85 alpha). p85 alpha is an adaptor molecule that regulates the activity of the catalytic p110 subunit by binding to phosphorylated receptor tyrosine kinases (RTKs) through its SH2 domain and mediating the interaction between p110 and the plasma membrane. p85 alpha is necessary for insulin-stimulated increase in glucose uptake and glycogen synthesis in insulin-sensitive tissues.

Function : Binds to activated (phosphorylated) protein-Tyr kinases, through its SH2 domain, and acts as an adapter, mediating the association of the p110 catalytic unit to the plasma membrane. Necessary for the insulin-stimulated increase in glucose uptake and glycogen synthesis in insulin-sensitive tissues. Plays an important role in signaling in response to FGFR1, FGFR2, FGFR3, FGFR4, KITLG/SCF, KIT, PDGFRA and PDGFRB. Likewise, plays a role in ITGB2 signaling.

Subunit : Heterodimer of a regulatory subunit PIK3R1 and a p110 catalytic subunit (PIK3CA, PIK3CB or PIK3CD). Interacts with FER. Interacts (via SH2 domain) with TEK/TIE2 (tyrosine phosphorylated). Interacts with PTK2/FAK1 (By similarity). Interacts with phosphorylated TOM1L1. Interacts with phosphorylated LIME1 upon TCR and/or BCR activation. Interacts with SOCS7. Interacts with RUFY3. Interacts (via SH2 domain) with CSF1R (tyrosine phosphorylated). Interacts with LYN (via SH3 domain); this enhances enzyme activity (By similarity). Interacts with phosphorylated LAT, LAX1 and TRAT1 upon TCR activation. Interacts with CBLB. Interacts with HIV-1 Nef to activate the Nef associated p21-activated kinase (PAK). This interaction depends on the C-terminus of both proteins and leads to increased production of HIV. Interacts with HCV NS5A. The SH2 domains interact with the YTHM motif of phosphorylated INSR in vitro. Also interacts with tyrosine-phosphorylated IGF1R in vitro. Interacts with CD28 and CD3Z upon T-cell activation. Interacts with IRS1 and phosphorylated IRS4, as well as with NISCH and HCST. Interacts with FASLG, KIT and BCR. Interacts with AXL, FGFR1, FGFR2, FGFR3 and FGFR4 (phosphorylated). Interacts with FGR and HCK. Interacts with PDGFRA (tyrosine phosphorylated) and PDGFRB (tyrosine phosphorylated). Interacts with ERBB4 (phosphorylated). Interacts with NTRK1 (phosphorylated upon ligand-binding).

Tissue Specificity : Isoform 2 is expressed in skeletal muscle and brain, and at lower levels in kidney and cardiac muscle. Isoform 2 and isoform 4 are present in skeletal muscle (at protein level).

Phosphorylated. Tyrosine phosphorylated in response to signaling by FGFR1, FGFR2, FGFR3 and FGFR4. Phosphorylated by CSF1R. Phosphorylated by ERBB4. Phosphorylated on tyrosine residues by TEK/TIE2. Dephosphorylated by PTPRJ. Phosphorylated by PIK3CA at Ser-608; phosphorylation is stimulated by insulin and PDGF. The relevance of phosphorylation by PIK3CA is however unclear. Phosphorylated in response to KIT and KITLG/SCF. Phosphorylated by FGR.

Similarity : Belongs to the PI3K p85 subunit family.

Contains 1 Rho-GAP domain.

Contains 2 SH2 domains.

Contains 1 SH3 domain.

Database links : UniProtKB/Swiss-Prot: P27986.2

實(shí)驗(yàn)流程:

正在熱銷的相關(guān)產(chǎn)品:

sTNF Alpha-RI(humen) 人可溶性壞死因子-受體1Multi-class antibodies規(guī)格: 48T

Anti-C-Mer/MERTK c-mer原癌基因酪氨酸激酶抗體Multi-class antibodies規(guī)格: 0.1ml

Rhesus antibody Rh NPY/Neuropeptide Y 神經(jīng)肽Y抗體 規(guī)格 0.1ml

SP Kit(Broad Spectrum) 廣譜SP免疫組化檢測(cè)試劑盒(用于檢測(cè)兔、大鼠、小鼠和豚鼠來源的一抗) 3ml

TCHP 英文名稱: 蛋白TCHP抗體 0.2ml

C7orf13 英文名稱: 7號(hào)染色體開放閱讀框13抗體 0.2ml

Anti-C-Mer/MERTK c-mer原癌基因酪氨酸激酶抗體Multi-class antibodies規(guī)格: 0.1ml

Anti-IL-10/FITC 熒光素標(biāo)記白介素10抗體IgGMulti-class antibodies規(guī)格: 0.2ml

Anti-Phospho-PSD95 (Tyr236/Tyr240) /FITC 熒光素標(biāo)記磷酸化突觸后密度蛋白95抗體IgGMulti-class antibodies規(guī)格: 0.2ml

Rhesus antibody Rh APOA4 載脂蛋白A4抗體 規(guī)格 0.2ml

Rabbit Anti-rat IgM/Cy5.5 Cy5.5標(biāo)記的兔抗大鼠IgM 0.1ml

GABABR1 英文名稱: gamma基B型受體1抗體 0.2ml

Rhesus antibody Rh Rabbit Anti-human sIgA/PE-CY5 PE-CY5標(biāo)記的兔抗人分泌型IgA 規(guī)格 0.1ml

Anti-Phospho-PSD95 (Tyr236/Tyr240) /FITC 熒光素標(biāo)記磷酸化突觸后密度蛋白95抗體IgGMulti-class antibodies規(guī)格: 0.2ml

Cytochrome-C 小鼠細(xì)胞色素CMulti-class antibodies規(guī)格: 48T

Anti-Fibulin 1 “衰老關(guān)鍵蛋白”抗體Multi-class antibodies規(guī)格: 0.2ml

Rhesus antibody Rh Mouse Anti-Rabbit IgM/AP 堿性磷酸酶(AP)標(biāo)記的小鼠抗兔IgM 規(guī)格 0.1ml

AhR(Human aryl hydrocarbon receptor) ELISA Kit 人芳香烴受體 96T

SIX2 英文名稱: 轉(zhuǎn)錄因子同源框蛋白SIX2抗體 0.2ml

CD163L1 英文名稱: CD163蛋白樣1抗體 0.1ml

Anti-Fibulin 1 “衰老關(guān)鍵蛋白”抗體Multi-class antibodies規(guī)格: 0.2ml

Crystalvioletbloodagarbase

DEV Lactose peptone broth DEV乳糖蛋白胨肉湯 1.10690.0500 MERCK默克 incubation media DEV Lactose peptone broth DEV乳糖蛋白胨肉湯 1.10690.0500 MERCK默克

馬鈴薯葡萄糖半固體瓊脂 250g 用于椰毒假單胞菌酵米面亞種的產(chǎn)毒培養(yǎng)

脂肪間質(zhì)干細(xì)胞成脂誘導(dǎo)分化培養(yǎng)基Adultadiposederivedmesenchymalstemcellsintotheculturemediuminduceddifferentiationoffat

MFBMedium

InorganicAgar

麥芽浸粉肉湯(MEB) 250(g) incubation media 麥芽浸粉肉湯(MEB) 250(g)

大腸桿菌&大腸菌群顯色培養(yǎng)基配套平皿 E.Coli&Coliform Chromogenic Medium Dish 9㎝/塊

LBS瓊脂incubationmediaLBS瓊脂

NaClNutrientAgar

磷酸化磷脂酰肌醇激酶抗體規(guī)格 改良克氏雙糖培養(yǎng)基  規(guī)格:  250g  用途:  用于小腸耶爾森氏菌的鑒定

鹽蛋白胨水培養(yǎng)基  規(guī)格:  250g  用途:  用于鑒別綠膿桿菌分解鹽產(chǎn)氣試驗(yàn)

半固體瓊脂  規(guī)格:  250g  用途:  供細(xì)菌動(dòng)力觀察、菌種保存,H抗原位相變異試驗(yàn)等。(美國FDA、SN、GB)

3%三糖鐵瓊脂  規(guī)格:  250g  用途:  用于副溶血性弧菌的生化反應(yīng)。(GB、SN)

技術(shù)外包服務(wù):

磷酸化磷脂酰肌醇激酶抗體規(guī)格 分子生物學(xué):質(zhì)粒抽提、PCRQ-PCR、RT-PCR、分子生物學(xué):基因合成、引物合成、基因測(cè)序、載體構(gòu)建等

蛋白工程:原核、哺乳動(dòng)物蛋白表達(dá)系統(tǒng)等

病毒包裝:腺病毒、慢病毒等

抗體工程:磁珠分選、病理染色、WB、ELISA、IP、IFIHC、FACSConfocal等等

細(xì)胞工程:細(xì)胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細(xì)胞培養(yǎng)、細(xì)胞膜制備、穩(wěn)定細(xì)胞株構(gòu)建、細(xì)胞RNAi技術(shù)等等。


聯(lián)系方式
手機(jī):13585831301
Q Q:
亚洲精品乱码久久久久久久久久久久,国产精品视频色尤物yw,亚洲AV日韩AV永久无码色欲,亚洲a∨精品永久无码